Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00358852
Status:
COMPLETED
Last Update Posted:
2014-03-19
First Post:
2006-07-28
Brief Title:
Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia
Sponsor:
Janssen-Cilag SA
Organization:
Janssen-Cilag SA
Study Overview
Official Title:
Scale Validation of Prediction of Relapse and Rehospitalization Short Term in Patients With Schizophrenia
Status:
COMPLETED
Status Verified Date:
2014-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRE-COG
Brief Summary:
The purpose of this study is to establish and validate a scalemodel that can be used to evaluate the duration of time and factors between short term hospital treatment and subsequent relapse periods in patients with schizoaffectiveschizophreniform disorders
Detailed Description:
This is an epidemiological study of the distribution and determinants of health-related states or events in defined population multicenter study conducted at multiple sites observational study in which patients are observed cross-sectional observation of all patients at one specific point in time prospective in which the patients are first identified and then followed forward as time passes study The sources of information in the study are units medical short stay psychiatric hospitalization or the acute care of the whole country and clinical data of the patient at discharge No intervention will be provided in this study The general data age range gender highest level of educational attainment level of family support substance abuse events stressors type of schizophrenia according to DSM-IV criteria Diagnostic and Statistical Manual fourth etc of approximately 2000 schizophrenia and schizoaffective disorder schizophreniform patients will be collected in this study No special tests will be done during the study The study will collect patients data in electronic data collection workbook and model validation will be used at 6 and 12 months to confirm no relapse hospitalization The study observation period corresponds to the 3 years preceding the current relapse and current income current hospitalization period and 12 months after admission
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| RISSCH4075 | OTHER | Janssen-Cilag SA Spain | None |